@FierceBiotech: The 2013 Fierce 15 biotech execs take a bow. Editor's corner | FierceBiotech's 2013 Fierce 15 | Follow @FierceBiotech
@JohnCFierce: Merck KGaA doubles down on Oncothyreon's failed cancer vaccine. Report | Follow @JohnCFierce
@DamianFierce: Apparently no one wanted to spend ~$3B on Clovis Oncology. Perhaps Big Pharma wants its biotechs to generate revenue. Story | Follow @DamianFierce
@EmilyMFierce: Stem cell reprogramming made easier by removing one protein. Popular yesterday from FierceBiotech Research | Follow @EmilyMFierce
> Rockville, MD-based Novavax ($NVAX) plans to raise $82 million from the sale of common stock. The new financing is intended to finance work on its pipeline of vaccines. Release
> South San Francisco-based Achaogen and the FDA have reached agreement on an SPA for a Phase III clinical trial of plazomicin in patients with serious multi-drug resistant gram-negative bacterial infections. Release
> San Diego-based La Jolla Pharmaceutical says it has raised $10 million in a new financing effort. Release
Medical Device News
@FierceMedDev: Biocept Laboratories becomes latest Dx outfit to explore IPO. ICYMI yesterday | Follow @FierceMedDev
@MarkHFierce: Medtronic won expanded indications for one of its key vascular stents. Release | Article | Follow @MarkHFierce
> Stryker inks $1.7B deal for Mako. News
> Tool to predict bad implant reactions shows potential. Item
> EnteroMedics slides after FDA squints at obesity device. Article
Pharma News
@FiercePharma: Lundbeck's refusal to sell pentobarbital to prisons hits Ohio's execution plans. More from Reuters | Follow @FiercePharma
@EricPFierce: FDA warning letter for Strides Arcolab Agila Speciaities plant arrives. Mylan not too concerned. Story from FiercePharmaManufacturing | Follow @EricPFierce
> Cost gatekeepers give final 'no' to Pfizer's targeted cancer drug Xalkori. Report
> Eli Lilly's diabetes strategy doesn't include big staff-up in sales. Article
Drug Delivery News
@MichaelGFierce: Laser-sensitive surface enables IV-drug identification for safer delivery. Story | Follow @MichaelGFierce
> Study: Artificial pancreas with inhaled insulin improves glucose control. More
> Alnylam heralds positive results for RNAi amyloidosis drug. Article
> Surefire collects $16.4M to expand cancer-drug catheter biz. Item
> Bind collects $70.5M IPO to support Accurin tech. Story
Diagnostics News
> Cognoptix Alzheimer's eye test generates robust trial results. Article
> Alzheimer's diagnosis may gain from PET imaging of tau proteins. Report
> Case Western, GSK find promise with MS diagnostic 'probe.' Story
> In vitro Dx to remain at top of med tech heap. More
> Cigna: Genetic counseling mandates will come for other Dx tests. Article
And Finally… A nail fungus drug has been proven effective at wiping out HIV in cell cultures. Story